InsiderClue
Insiders · Profile

Randhawa Simrat

EVP, Head of R&D at Dianthus Therapeutics, Inc. /DE/. Filing since 21 Sep 2023. CIK 0001992260

Company
Date
Role
Action
Shares
Amount
Of holding
DNTH Dianthus Therapeutics, Inc. /DE/
1 Sep 2026
EVP, Head of R&D
Sold on a plan
23,124
$2.46M
85.3%
DNTH Dianthus Therapeutics, Inc. /DE/
1 Jun 2026
EVP, Head of R&D
Sold on a plan
26,530
$2.40M
86.9%
DNTH Dianthus Therapeutics, Inc. /DE/
12 Mar 2026
EVP, Head of R&D
Sold on a plan
33,830
$2.76M
100%
DNTH Dianthus Therapeutics, Inc. /DE/
14 Nov 2025
EVP, Head of R&D
Sold on a plan
109,031
$4.16M
96.5%
DNTH Dianthus Therapeutics, Inc. /DE/
13 Nov 2025
EVP, Head of R&D
Sold on a plan
87,507
$3.22M
95.6%
DNTH Dianthus Therapeutics, Inc. /DE/
22 Sep 2023
Chief Medical Officer
Bought
2,000
$26.40K
100%
DNTH Dianthus Therapeutics, Inc. /DE/
21 Sep 2023
Chief Medical Officer
Bought
2,000
$26.40K
opened
7 decisions on file.